EUVIMEDEUVIMED entdecken
Crossref

Dalbavancin: a new option for systemic treatment of Gram-positive endogenous endophthalmitis?

Antoine Hamon, Sihem Benaboud, Mickael Anjou, Benjamin Thoreau, Daphné Dedieu, Antoine Brezin, Léo Froelicher Bournaud, Asmaa Tazi, Caroline Charlier iD, Etienne Canouï iD

Journal of Antimicrobial Chemotherapy · 2023

DOI: 10.1093/jac/dkad308 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2023. Verfasst von Antoine Hamon und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculté de Médecine, Université Paris Cité, F-75006 Paris, France. Hauptthemen laut MEDLINE: Endophthalmitis, Gram-Positive Bacterial Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndophthalmitisGram-Positive Bacterial InfectionsHumansTeicoplaninAnti-Bacterial AgentsGram-Positive Bacteria

Substanzen

dalbavancinTeicoplaninAnti-Bacterial Agents

Autor:innen und Institutionen

  • Faculté de Médecine, Université Paris Cité, F-75006 Paris, France.
  • Équipe Mobile d'Infectiologie, AP-HP, APHP.CUP, Hôpital Cochin, F-75014 Paris, France.
  • Service de Pharmacologie, AP-HP, APHP.CUP, Hôpital Cochin, F-75014 Paris, France.
  • Service d'Ophtalmologie, AP-HP, APHP.CUP, Hôpital Cochin, F-75014 Paris, France.
  • Service de Médecine Interne, AP-HP, APHP.CUP, Hôpital Cochin, F-75014 Paris, France.
  • Service de Bactériologie, AP-HP, APHP.CUP, Hôpital Cochin, F-75014 Paris, France.

ORCID-Profile: Caroline Charlier, Etienne Canouï

Zitieren

APA

Hamon, A., Benaboud, S., Anjou, M., Thoreau, B., Dedieu, D., Brezin, A., Froelicher Bournaud, L., Tazi, A., Charlier, C., & Canouï, E. (2023). Dalbavancin: a new option for systemic treatment of Gram-positive endogenous endophthalmitis?. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkad308

Vancouver

Hamon A, Benaboud S, Anjou M, Thoreau B, Dedieu D, Brezin A, et al. Dalbavancin: a new option for systemic treatment of Gram-positive endogenous endophthalmitis?. Journal of Antimicrobial Chemotherapy. 2023. doi:10.1093/jac/dkad308

BibTeX
@article{Hamon2023,
  author = {Hamon, Antoine and Benaboud, Sihem and Anjou, Mickael and Thoreau, Benjamin and Dedieu, Daphné and Brezin, Antoine and Froelicher Bournaud, Léo and Tazi, Asmaa and Charlier, Caroline and Canouï, Etienne},
  title = {Dalbavancin: a new option for systemic treatment of Gram-positive endogenous endophthalmitis?},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2023},
  doi = {10.1093/jac/dkad308}
}
Kostenlos starten →